Control and monitoring of lipoprotein levels in atherosclerosis induced rabbits using novel nanoparticulate medication of Lovastatin and Rosuvastatin
Abstract Different epidemiological studies have demonstrated higher level of uric acid and Lipoprotein levels as risk factors for atherosclerosis. The present investigation deals with formulation of novel combination of Rosuvastatin and Lovastatin in nanoparticulate form to assess atherosclerosis mo...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-09-01
|
Series: | Micro & Nano Letters |
Online Access: | https://doi.org/10.1049/mna2.12081 |